Millipore and Stem Cell Sciences Announce Agreement To Provide Human Embryonic Stem Cell Media
Wednesday October 25, 7:00 am ET
Breakthrough Product Will Provide Significant Advantages to Researchers Studying Human Embryonic Stem Cells
BILLERICA, Mass.--(BUSINESS WIRE)--Millipore Corporation and Stem Cell Sciences (SCS) today announced an exclusive license for Millipore to develop and market SCS' serum free media for the growth of human embryonic stem cells (hESCs). The defined media will be the first product available in the industry that offers improved methods for growing hESCs without the need for animal serum.
By eliminating the need for serum, researchers can generate improved experimental results by avoiding interference from animal products in the media, which will improve the ease of use and reliability in growing hESCs. The lack of animal-free, defined media for growing hESCs has been an important technical hurdle in enabling researchers to advance their understanding of the therapeutic value of stem cells.
"Millipore is committed to being the most innovative supplier of products to the stem cell research market," said Dominique Baly, President of Millipore's Bioscience Division. "Our agreement with SCS reflects the significant investments we are making to serve the needs of researchers exploring the therapeutic value of stem cells. We chose SCS because their media worked extremely well in growing hESCs in a variety of different stem cell lines and conditions and they had the most advanced development of serum-free media."
Under the terms of the agreement, Millipore will manufacture, market and sell the new media under the brand name HEScGRO Embryonic Stem Cell Medium. SCS will receive royalties from all future sales of HEScGRO Embryonic Stem Cell Medium. The agreement builds on the successful collaboration between Millipore and SCS formed in 2005 to commercialize media for the growth of mouse embryonic cells. Millipore's ESGRO Complete(TM) is the leading product used by researchers today for mouse stem cell experimentation.
SCS Vice President and Chief Operating Officer, Hugh Ilyine said: "As researchers investigate using stem cells to create cures for new diseases, the use of hESCs are critical. By providing serum-free media to grow hESCs, scientists can be confident that the effects they are studying in the laboratory are from the cell itself and not from animal products in the media. The expansion of our agreement with Millipore will allow researchers to now benefit from products offering superior performance in both mouse and human stem cell research."
Millipore expects to have HEScGRO Embryonic Stem Cell Medium available for commercial distribution before the end of the year. HEScGRO has been shown to be effective at growing many different human embryonic stem cell lines, including lines that have been approved by the U.S. government for use in federally sponsored research, as well as the "Mel" hES cell lines derived by Stem Cell Sciences in Australia and distributed by Millipore. Millipore offers a broad range of products and reagents for stem cell research through its Chemicon product line, which is part of the company's Research Reagents Business Unit.
Millipore Research Reagents Business Unit creates innovative and high quality biological reagents for life science researchers to conduct their experiments consistently. These biological reagents include antibodies, dyes and biochemical reagents that are used to identify and measure cellular interactions, cell signaling and other cellular functions.
Source: Millipore Corporation
Engineering News Archive